Minireview: Hexose-6-Phosphate Dehydrogenase and Redox Control of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Hexose-6-phosphate dehydrogenase (H6PDH) is a microsomal enzyme that is able to catalyze the first two reactions of an endoluminal pentose phosphate pathway, thereby generating reduced nicotinamide adenine dinucleotide phosphate (NADPH) within the endoplasmic reticulum. It is distinct from the cytosolic enzyme, glucose-6-phosphate dehydrogenase (G6PDH), using a separate pool of NAD(P)+ and capable of oxidizing several phosphorylated hexoses. It has been proposed to be a NADPH regenerating system for steroid hormone and drug metabolism, specifically in determining the set point of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity, the enzyme responsible for the activation and inactivation of glucocorticoids. 11β-HSD1 is a bidirectional enzyme, but in intact cells displays predominately oxo-reductase activity, a reaction requiring NADPH and leading to activation of glucocorticoids. However, in cellular homogenates or in purified preparations, 11β-HSD1 is exclusively a dehydrogenase. Because H6PDH and 11β-HSD1 are coexpressed in the inner microsomal compartment of cells, we hypothesized that H6PDH may provide 11β-HSD1 with NADPH, thus promoting oxo-reductase activity in vivo. Recently, several studies have confirmed this functional cooperation, indicating the importance of intracellular redox mechanisms for the prereceptor control of glucocorticoid availability. With the increased interest in 11β-HSD1 oxo-reductase activity in the pathogenesis and treatment of several human diseases including insulin resistance and the metabolic syndrome, H6PDH represents an additional novel candidate for intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712 · cited 1×
“activate the mineralocorticoid receptor in vivo (22, 23).”
BackgroundTissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1418 · Cited by 655 · cited 1×
“They should also raise increased awareness of the pitfalls of measuring only 11 -dehydrogenase activity in vitro and inferring from this that this is representative of 11-oxo-reductase activity in vivo (42).”
BackgroundLAKSHMI, V., & MONDER, C. (1988) · Endocrinology · doi:10.1210/endo-123-5-2390 · Cited by 311
HAUNER, H., SCHMID, P., & PFEIFFER, E. F. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-832 · Cited by 308 · cited 1×
“tissue; here its oxo-reductase activity has been implicated in the pathogenesis of the metabolic syndrome through increased local generation of cortisol facilitating hepatic glucose output (28) and adipocyte differentiation (29).”
BackgroundJamieson, P. M., Chapman, K. E., Edwards, C. R. W., & Seckl, J. R. (1995) · Endocrinology · doi:10.1210/en.136.11.4754 · Cited by 301
Type I Glycogen Storage Diseases: Disorders of the Glucose-6- Phosphatase Complex
Chou, J., Matern, D., Mansfield, B., & Chen, Y.-T. (2002) · Current Molecular Medicine · doi:10.2174/1566524024605798 · Cited by 298 · cited 1×
“Supply of G6P is ensured by the glucose-6-phosphate transporter of the ER, which is specific for G6P (7).”
BackgroundDraper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285 · cited 1×
“candidates are likely to be involved (38).”
Self-citationAlberts, P., Nilsson, C., Selén, G., Engblom, L. O. M., Edling, N. H. M., Norling, S., Klingström, G., Larsson, C., Forsgren, M., Ashkzari, M., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0344 · Cited by 263 · cited 1×
“Inhibition of 11 -HSD1, using selective inhibitors, has resulted in improved insulin sensitivity and weight loss (30, 31), but the factors determining 11 -HSD1 set point and oxo-reductase activity per se have remained elusive.”
BackgroundBujalska, I. J., Kumar, S., Hewison, M., & Stewart, P. M. (1999) · Endocrinology · doi:10.1210/endo.140.7.6868 · Cited by 254 · cited 1×
“(33), where differences in oxoreductase-dehydrogenase activities of 11 -HSD1 in human omental and sc adipose stromal cells could not be explained by differences in G6PDH activity.”
BackgroundSelf-citationGlucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239 · cited 1×
“Additionally, neuronal cells have also been shown to have bidirectional activity (37).”
BackgroundAtanasov, A. G., Nashev, L. G., Schweizer, R. A. S., Frick, C., & Odermatt, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.065 · Cited by 210
Stewart, P. M. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.480 · Cited by 180 · cited 1×
“activate the mineralocorticoid receptor in vivo (22, 23).”
BackgroundSelf-citationBánhegyi, G., Benedetti, A., Fulceri, R., & Senesi, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404159200 · Cited by 168
Bujalska, I. J., Draper, N., Michailidou, Z., Tomlinson, J. W., White, P. C., Chapman, K. E., Walker, E. A., & Stewart, P. M. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01718 · Cited by 165
Self-citationBujalska, I. J. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1205 · Cited by 157 · cited 1×
“Thus, after 14 d of culture under conditions that promote adipocyte differentiation, a switch occurs from 11 HSD1 dehydrogenase to oxo-reductase activity in omental preadipocytes (36), despite no change in absolute levels of enzyme expression.”
BackgroundSelf-citationExpression of 11β-hydroxysteroid dehydrogenase using recombinant vaccinia virus
Agarwal, A. K., Tusie-Luna, M.-T., Monder, C., & White, P. C. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-12-1827 · Cited by 155
Localization and Characteristics of Hexose 6-Phosphate Dehydrogenase (Glucose Dehydrogenase)
Beutler, E., & Morrison, M. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99426-3 · Cited by 127 · cited 1×
“Initially, H6PDH was reported to have dehydrogenase activity on G6P and galactose-6-phosphate, but further studies show that it has a broader substrate specificity incorporating other hexose-6-phosphates such as 2-deoxyglucose 6-phosphate, and also simple sugars such as glucose (1, 5).”
BackgroundLivingstone, D. E. W., & Walker, B. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044842 · Cited by 99 · cited 1×
“Inhibition of 11 -HSD1, using selective inhibitors, has resulted in improved insulin sensitivity and weight loss (30, 31), but the factors determining 11 -HSD1 set point and oxo-reductase activity per se have remained elusive.”
BackgroundGe, R.-S., Hardy, D. O., Catterall, J. F., & Hardy, M. P. (1997) · Endocrinology · doi:10.1210/endo.138.12.5614 · Cited by 81 · cited 1×
“Rat Leydig cells, depending upon their stage of differentiation and testosterone secreting ability, vary significantly in underlying oxo-reductase compared with dehydrogenase activities (34).”
BackgroundRicketts, M., Shoesmith, K., Hewison, M., Strain, A., Eggo, M., & Stewart, P. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560159 · Cited by 80 · cited 1×
“In intact cells, 11 -HSD1 is a bidirectional enzyme, predominately displaying oxo-reductase activity (24, 25), but in cel-”
BackgroundSelf-citationOzols, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5302 · Cited by 71 · cited 2×
“The H6PDH amino acid sequence was first determined from rabbit liver microsomes (19), and thus far has provided the only protein sequence data for this enzyme.”
BackgroundWalker, E. A., Clark, A. M., Hewison, M., Ride, J. P., & Stewart, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011142200 · Cited by 65 · cited 2×
“can be restored in vitro by the addition of G6PDH and NADP to regenerate NADPH (27, 32).”
BackgroundSelf-citationRetention of membrane proteins by the endoplasmic reticulum.
Brands, R., Snider, M. D., Hino, Y., Park, S. S., Gelboin, H. V., & Rothman, J. E. (1985) · The Journal of Cell Biology · doi:10.1083/jcb.101.5.1724 · Cited by 64 · cited 1×
“Carbohydrate is attached to Asn138 and Asn-263, in keeping with its endoluminal orientation (19, 20), although the protein lacks a conventional ER signal”
BackgroundHexose-6-phosphate dehydrogenase: Distribution in rat tissues and effect of diet, age and steroids
Mandula, B., Sk, S., & Beutler, E. (1970) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(70)90118-9 · Cited by 62 · cited 2×
“A further study in 1970 (16) reported a rapid increase in H6PDH activity before birth in rats, with a decline to adult levels 30 d postpartum.”
BackgroundClarke, J. L., Scopes, D., Sodeinde, O., & Mason, P. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02078.x · Cited by 61 · cited 1×
“dium falciparum and Plasmodium berghei G6PDH proteins (21)”
BackgroundThe pentose phosphate pathway in the endoplasmic reticulum.
Bublitz, C., & Steavenson, S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37638-5 · Cited by 61 · cited 1×
“Sequence comparisons revealed the possibility that H6PDH is a bifunctional enzyme, and in addition to its oxidative activity on G6P it is thought to catalyze the hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate (10), performing in effect the first two steps of a pentose phosphate pathway within the ER (11).”
BackgroundClarke, J. L., & Mason, P. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00229-7 · Cited by 61 · cited 1×
“The murine enzyme has been proven to have bifunctional activity (13), but this has yet to be confirmed for human H6PDH.”
BackgroundCollard, F., Collet, J., Gerin, I., Veiga‐da‐Cunha, M., & SCHAFTINGEN, E. V. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01247-8 · Cited by 56 · cited 2×
“and the human cytosolic 6PGL protein (10).”
BackgroundMason, P. J., Stevens, D., Díez, A., Knight, S. W., Scopes, D. A., & Vulliamy, T. (1999) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1999.0224 · Cited by 47 · cited 3×
“Subsequently, activity has been reported in many human tissues including liver, placenta, lymphoid, fibroblasts, adipose, white blood cells, kidney, thymus, pancreas, ovary, testis, skeletal muscle, and lung (3, 12, 17, 18), with the highest activity observed in liver and placenta.”
BackgroundGLUCOSE 6‐PHOSPHATE DEHYDROGENASE AND HEXOSE 6‐PHOSPHATE DEHYDROGENASE OF MAMMALIAN TISSUES*
Shaw, C. R., & Koen, A. L. (1968) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1968.tb11884.x · Cited by 45 · cited 1×
“Preliminary studies carried out in the 1960s indicated that the levels of H6PDH were higher in female mice than male, suggesting hormonal regulation of H6PDH; however, levels were not altered across pregnancy or lactation (15).”
BackgroundSawada, H., Hayashibara, M., Hara, A., & Nakayama, T. (1980) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a132829 · Cited by 41 · cited 1×
“is relatively impermeable to pyridine nucleotides, the supply of NAD(P) must be maintained through a functional cooperation between H6PDH (and perhaps additional oxidases) and intraluminal reductases (6, 8, 9).”
BackgroundImmunohistochemical localization of hexose 6-phosphate dehydrogenase in various organs of the rat.
Tanahashi, K., & Hori, S. H. (1980) · Journal of Histochemistry & Cytochemistry · doi:10.1177/28.11.7430614 · Cited by 36 · cited 2×
“This localization to steroidogenic cells, liver cells, and renal tissue further supports the hypothesis that H6PDH may be involved in drug and steroid metabolism (4).”
BackgroundJones, C. G., Hothi, S. K., & Titheradge, M. A. (1993) · Biochemical Journal · doi:10.1042/bj2890821 · Cited by 36 · cited 1×
“tissue; here its oxo-reductase activity has been implicated in the pathogenesis of the metabolic syndrome through increased local generation of cortisol facilitating hepatic glucose output (28) and adipocyte differentiation (29).”
BackgroundFerguson, S., Pallikaros, Z., Michael, A. E., & COOKE, B. A. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00186-0 · Cited by 33 · cited 1×
“This could be manipulated by altering key components within culture media including the omission of glucose, NAD , NADH, NADP (35).”
BackgroundKIMURA, K., ENDOU, H., SUDO, J.-I., & SAKAI, F. (1979) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a132336 · Cited by 27 · cited 1×
“14 10 4 m for 2-deoxyglucose 6-phosphate have been documented (14).”
BackgroundRomanelli, A., St-Denis, J.-F., Vidal, H., Tchu, S., & Vandewerve, G. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1619 · Cited by 26 · cited 1×
“Initially, H6PDH was reported to have dehydrogenase activity on G6P and galactose-6-phosphate, but further studies show that it has a broader substrate specificity incorporating other hexose-6-phosphates such as 2-deoxyglucose 6-phosphate, and also simple sugars such as glucose (1, 5).”
BackgroundSawada, H., Hara, A., HAYASHIBARA, M., Nakayama, T., Usui, S., & Saeki, T. (1981) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a133559 · Cited by 23 · cited 1×
“is relatively impermeable to pyridine nucleotides, the supply of NAD(P) must be maintained through a functional cooperation between H6PDH (and perhaps additional oxidases) and intraluminal reductases (6, 8, 9).”
BackgroundPhenobarbital-induced increase of the hexose 6-phosphate dehydrogenase activity
Hori, S. H., & Takahashi, T. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(74)90263-0 · Cited by 22 · cited 2×
“In fact, it has long been suggested that the role of H6PDH is to supply reduced NAD(P) to ER reductases involved specifically with steroid and drug metabolism (2).”
BackgroundMouse liver microsomal hexose-6-phosphate dehydrogenase
Kulkarni, A. P., & Hodgson, E. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90353-7 · Cited by 20 · cited 4×
“is relatively impermeable to pyridine nucleotides, the supply of NAD(P) must be maintained through a functional cooperation between H6PDH (and perhaps additional oxidases) and intraluminal reductases (6, 8, 9).”
BackgroundInfluentialGlucose dehydrogenase polymorphism in man
KING, J., & Cook, P. J. L. (1981) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1981.tb00314.x · Cited by 18 · cited 1×
“Subsequently, activity has been reported in many human tissues including liver, placenta, lymphoid, fibroblasts, adipose, white blood cells, kidney, thymus, pancreas, ovary, testis, skeletal muscle, and lung (3, 12, 17, 18), with the highest activity observed in liver and placenta.”
BackgroundHexose-6-phosphate dehydrogenase from human tissues: An electrophoretic study in health and disease
Blume, K. G., Schmidt, G. M., Heissmeier, H. H., & Löhr, G. W. (1975) · Cellular and Molecular Life Sciences · doi:10.1007/bf02026401 · Cited by 14 · cited 1×
“Subsequently, activity has been reported in many human tissues including liver, placenta, lymphoid, fibroblasts, adipose, white blood cells, kidney, thymus, pancreas, ovary, testis, skeletal muscle, and lung (3, 12, 17, 18), with the highest activity observed in liver and placenta.”
BackgroundBarash, V., Erlich, T., & Bashan, N. (1990) · PubMed · Cited by 11
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
BÁNHEGYI, G., BAUMEISTER, P., BENEDETTI, A., DONG, D., FU, Y., LEE, A. S., LI, J., MAO, C., MARGITTAI, É., NI, M., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.007 · Cited by 262
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
“Although questions remain about the regulation and dysregulation of 11 HSD-1 and its role as cause or effect in visceral obesity (146, 149, 150), this cortisolgenerating system within adipose is significant for its local integration of energy homeostasis under normal conditions and for its potential as a target for ph…”
BackgroundGeay, F., Ferraresso, S., Zambonino-Infante, J. L., Bargelloni, L., Quentel, C., Vandeputte, M., Kaushik, S., Cahu, C. L., & Mazurais, D. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-522 · Cited by 184
“Moreover, our data indicate an increase in the expression of hexose-6-phosphate dehydrogenase (h6pdh) and phosphogluconate dehydrogenase (pgd), enzymes of the pentose phosphate pathway that generate NADPH, in fish fed VD [59,60] (Figure 2).”
BackgroundCooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Self-citation
Metadata
- Authors
- Hewitt, K. N., Walker, E. A., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- ORCID
- Stewart, Paul M.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-06-01
- Volume
- 146
- Issue
- 6
- Pages
- 2539-2543
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2062256053
- Semantic Scholar
- f1688d0d0bec0ec882986aab5aa549e0384f021c
- Cited by
- 149
- References
- 43
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hexose-6-phosphate dehydrogenase, 11β-hydroxysteroid dehydrogenase type 1, NADPH regeneration, redox regulation, pentose phosphate pathway, endoplasmic reticulum, microsomal enzymes, insulin resistance, metabolic syndrome, steroid hormone metabolism
- MeSH terms
- Animals, Carbohydrate Dehydrogenases, Energy Metabolism, Humans, Oxidation-Reduction, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.